Marcellusi, Andrea, et al. “[Cost-Effectiveness Analysis of Maribavir in Patients With Post-Transplant Cytomegalovirus Infection or Disease That Are Refractory or Resistant to Conventional Therapy]”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 24, no. 1, Dec. 2023, doi:10.7175/fe.v24i1.1548.